TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
19 hedge funds and large institutions have $2.2M invested in Trillium Therapeutics Inc. in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$90.5K | |
| 2 | +$24.4K | |
| 3 | +$11K | |
| 4 |
VF
Virtu Financial
New York
|
+$6K |
Top Sellers
| 1 | -$112K | |
| 2 | -$99K | |
| 3 | -$73K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$65K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$62K |